{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:34Z","timestamp":1784673694245,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ijgc-2021-002472","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T05:30:11Z","timestamp":1646631011000},"page":"297-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["External beam management of stage I and II uterine cancer"],"prefix":"10.1016","volume":"32","clinical-trial-number":[{"clinical-trial-number":"nct04458597","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Donna Marie","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002472_bb0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002472_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2021-002472_bb0020","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.ejca.2015.08.031","article-title":"Insulin resistance and endometrial cancer risk: a systematic review and meta-analysis","volume":"51","author":"Hernandez","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2021-002472_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002472_bb0030","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-002472_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107327480901600107","article-title":"Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes","volume":"16","author":"Mendivil","year":"2009","journal-title":"Cancer Control"},{"key":"10.1136\/ijgc-2021-002472_bb0040","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002472_bb0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0060","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002472_bb0065","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002472_bb0075","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-002472_bb0080","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002472_bb0085","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial","volume":"93","author":"de Boer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0095","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2021-002472_bb0100","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-Intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0110","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage Ic, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","article-title":"Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial","volume":"95","author":"Maggi","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002472_bb0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","article-title":"Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study","volume":"108","author":"Susumu","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0125","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2021-002472_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0140","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0360-3016(90)90133-5","article-title":"Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma","volume":"19","author":"Randall","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002472_bb0155","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0160","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0165","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-002472_bb0170","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(00)02787-2","article-title":"Topical butyrate for acute radiation proctitis: randomised, crossover trial","volume":"356","author":"Vernia","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002472_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-5-31","article-title":"Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients","volume":"5","author":"Chitapanarux","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2014.05.049","article-title":"Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial","volume":"90","author":"Nascimento","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0185","article-title":"Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2021-002472_bb0190","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2009.08.013","article-title":"Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology","volume":"78","author":"Muecke","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0195","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-Induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial","volume":"20","author":"Oscarsson","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0200","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.prro.2019.07.001","article-title":"Literature review of vaginal stenosis and dilator use in radiation oncology","volume":"9","author":"Damast","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.prro.2017.02.003","article-title":"Perceptions and practices regarding women's vaginal health following radiation therapy: a survey of radiation oncologists practicing in the United States","volume":"7","author":"Kachnic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1136\/ijgc-2021-002472_bb0220","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijrobp.2020.05.013","article-title":"Radiation-Induced insufficiency fractures after pelvic irradiation for gynecologic malignancies: a systematic review","volume":"108","author":"Razavian","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0225","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2007.08.005","article-title":"Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors","volume":"70","author":"Oh","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0230","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002472_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002472_bb0240","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4149\/neo_2013_043","article-title":"Evaluation of stereotactic body radiotherapy (SBRT) boost in the management of endometrial cancer","volume":"60","author":"Demiral","year":"2013","journal-title":"Neoplasma"},{"key":"10.1136\/ijgc-2021-002472_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brachy.2016.10.004","article-title":"Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy","volume":"16","author":"Kauffmann","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002472_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-9-164","article-title":"Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer","volume":"9","author":"Jones","year":"2014","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400598X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2400598X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:18:38Z","timestamp":1753229918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2400598X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1048891X2400598X"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002472","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External beam management of stage I and II uterine cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}